Will CBD Be Reclassified As A Drug? – The Latest Plot Twist
In our recent,
article – CBD
Novel Food – What’s Going on? We outlined the current climate for the
CBD industry in the EU and the UK.
In short, CBD
companies must submit complex scientific dossiers to prove the safety of
products containing cannabinoids, as the EU decided that cannabinoids had not
been consumed to a significant degree before 1997. Which is false.
Now, the EU has
pivoted on this stance whilst they decide if non-synthetic CBD is, in fact, a
narcotic drug, and not food…
Will The UK Food Standards Agency Follow Suit?
Luckily, the UK
FSA has confirmed that CBD will not be reclassified as a narcotic. Which is
welcoming news to the consumer and the many companies paying hundreds of
thousands on creating Novel Food dossiers.
However, there is
still huge uncertainty as to whether non-selective, full-spectrum CBD Oils will
be permitted for sale after 31 March 2021.
Full Spectrum CBD
Oils offer the most benefits to the consumer, as they contain hundreds
of active compounds that can benefit wellbeing. Furthermore, these compounds
can work in synergy to enhance the benefits
of CBD.
Whatever happens, we
will do everything we can to continue offering the most effective products
available at market leading prices.
20% Summer Sale!
We have slashed our
prices by 20% this summer – making our products even more affordable! To take
advantage of this fantastic offer, use discount code: Summer on
the ‘Cart’ page before checking out.
Comments